Cargando…

Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design

BACKGROUND: Adverse events (AEs) epidemiology is the first step to improve practice in the healthcare system. Usually, the preferred method used to estimate the magnitude of the problem is the retrospective cohort study design, with retrospective reviews of the medical records. However this data col...

Descripción completa

Detalles Bibliográficos
Autores principales: Aranaz Andrés, Jesus Maria, Limón Ramírez, Ramon, Aibar Remón, Carlos, Gea-Velázquez de Castro, Maria Teresa, Bolúmar, Francisco, Hernández-Aguado, Ildefonso, López Fresneña, Nieves, Díaz-Agero Pérez, Cristina, Terol García, Enrique, Michel, Philippe, Sousa, Paulo, Larizgoitia Jauregui, Itziar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640028/
https://www.ncbi.nlm.nih.gov/pubmed/28993382
http://dx.doi.org/10.1136/bmjopen-2017-016546
_version_ 1783270973497147392
author Aranaz Andrés, Jesus Maria
Limón Ramírez, Ramon
Aibar Remón, Carlos
Gea-Velázquez de Castro, Maria Teresa
Bolúmar, Francisco
Hernández-Aguado, Ildefonso
López Fresneña, Nieves
Díaz-Agero Pérez, Cristina
Terol García, Enrique
Michel, Philippe
Sousa, Paulo
Larizgoitia Jauregui, Itziar
author_facet Aranaz Andrés, Jesus Maria
Limón Ramírez, Ramon
Aibar Remón, Carlos
Gea-Velázquez de Castro, Maria Teresa
Bolúmar, Francisco
Hernández-Aguado, Ildefonso
López Fresneña, Nieves
Díaz-Agero Pérez, Cristina
Terol García, Enrique
Michel, Philippe
Sousa, Paulo
Larizgoitia Jauregui, Itziar
author_sort Aranaz Andrés, Jesus Maria
collection PubMed
description BACKGROUND: Adverse events (AEs) epidemiology is the first step to improve practice in the healthcare system. Usually, the preferred method used to estimate the magnitude of the problem is the retrospective cohort study design, with retrospective reviews of the medical records. However this data collection involves a sophisticated sampling plan, and a process of intensive review of sometimes very heavy and complex medical records. Cross-sectional survey is also a valid and feasible methodology to study AEs. OBJECTIVES: The aim of this study is to compare AEs detection using two different methodologies: cross-sectional versus retrospective cohort design. SETTING: Secondary and tertiary hospitals in five countries: Argentina, Colombia, Costa Rica, Mexico and Peru. PARTICIPANTS: The IBEAS Study is a cross-sectional survey with a sample size of 11 379 patients. The retrospective cohort study was obtained from a 10% random sample proportional to hospital size from the entire IBEAS Study population. METHODS: This study compares the 1-day prevalence of the AEs obtained in the IBEAS Study with the incidence obtained through the retrospective cohort study. RESULTS: The prevalence of patients with AEs was 10.47% (95% CI 9.90 to 11.03) (1191/11 379), while the cumulative incidence of the retrospective cohort study was 19.76% (95% CI 17.35% to 22.17%) (215/1088). In both studies the highest risk of suffering AEs was seen in Intensive Care Unit (ICU) patients. Comorbid patients and patients with medical devices showed higher risk. CONCLUSION: The retrospective cohort design, although requires more resources, allows to detect more AEs than the cross-sectional design.
format Online
Article
Text
id pubmed-5640028
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-56400282017-10-19 Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design Aranaz Andrés, Jesus Maria Limón Ramírez, Ramon Aibar Remón, Carlos Gea-Velázquez de Castro, Maria Teresa Bolúmar, Francisco Hernández-Aguado, Ildefonso López Fresneña, Nieves Díaz-Agero Pérez, Cristina Terol García, Enrique Michel, Philippe Sousa, Paulo Larizgoitia Jauregui, Itziar BMJ Open Public Health BACKGROUND: Adverse events (AEs) epidemiology is the first step to improve practice in the healthcare system. Usually, the preferred method used to estimate the magnitude of the problem is the retrospective cohort study design, with retrospective reviews of the medical records. However this data collection involves a sophisticated sampling plan, and a process of intensive review of sometimes very heavy and complex medical records. Cross-sectional survey is also a valid and feasible methodology to study AEs. OBJECTIVES: The aim of this study is to compare AEs detection using two different methodologies: cross-sectional versus retrospective cohort design. SETTING: Secondary and tertiary hospitals in five countries: Argentina, Colombia, Costa Rica, Mexico and Peru. PARTICIPANTS: The IBEAS Study is a cross-sectional survey with a sample size of 11 379 patients. The retrospective cohort study was obtained from a 10% random sample proportional to hospital size from the entire IBEAS Study population. METHODS: This study compares the 1-day prevalence of the AEs obtained in the IBEAS Study with the incidence obtained through the retrospective cohort study. RESULTS: The prevalence of patients with AEs was 10.47% (95% CI 9.90 to 11.03) (1191/11 379), while the cumulative incidence of the retrospective cohort study was 19.76% (95% CI 17.35% to 22.17%) (215/1088). In both studies the highest risk of suffering AEs was seen in Intensive Care Unit (ICU) patients. Comorbid patients and patients with medical devices showed higher risk. CONCLUSION: The retrospective cohort design, although requires more resources, allows to detect more AEs than the cross-sectional design. BMJ Publishing Group 2017-10-08 /pmc/articles/PMC5640028/ /pubmed/28993382 http://dx.doi.org/10.1136/bmjopen-2017-016546 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Public Health
Aranaz Andrés, Jesus Maria
Limón Ramírez, Ramon
Aibar Remón, Carlos
Gea-Velázquez de Castro, Maria Teresa
Bolúmar, Francisco
Hernández-Aguado, Ildefonso
López Fresneña, Nieves
Díaz-Agero Pérez, Cristina
Terol García, Enrique
Michel, Philippe
Sousa, Paulo
Larizgoitia Jauregui, Itziar
Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design
title Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design
title_full Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design
title_fullStr Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design
title_full_unstemmed Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design
title_short Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): cross-sectional versus retrospective cohort design
title_sort comparison of two methods to estimate adverse events in the ibeas study (ibero-american study of adverse events): cross-sectional versus retrospective cohort design
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640028/
https://www.ncbi.nlm.nih.gov/pubmed/28993382
http://dx.doi.org/10.1136/bmjopen-2017-016546
work_keys_str_mv AT aranazandresjesusmaria comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign
AT limonramirezramon comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign
AT aibarremoncarlos comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign
AT geavelazquezdecastromariateresa comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign
AT bolumarfrancisco comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign
AT hernandezaguadoildefonso comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign
AT lopezfresnenanieves comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign
AT diazageroperezcristina comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign
AT terolgarciaenrique comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign
AT michelphilippe comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign
AT sousapaulo comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign
AT larizgoitiajaureguiitziar comparisonoftwomethodstoestimateadverseeventsintheibeasstudyiberoamericanstudyofadverseeventscrosssectionalversusretrospectivecohortdesign